Ingles Markets Pharmacy #43 Community/Retail Pharmacy Location: 2901 Hendersonville Rd, Fletcher, North Carolina 28732 Phone: (828) 684-2838 |
Medpartners, Corp. Durable Medical Equipment & Medical Supplies Location: 450 Airport Rd, Fletcher, North Carolina 28732 Phone: (888) 572-3330 |
Cvs Pharmacy #04197 Durable Medical Equipment & Medical Supplies Location: 3450 Hendersonville Rd, Fletcher, North Carolina 28732 Phone: (828) 684-2331 |
Orthopedic Appliance Co, Inc Prosthetic/Orthotic Supplier Location: 235 St John Rd, Fletcher, North Carolina 28732 Phone: (828) 254-6305 |
Skyland Prosthetics & Orthotics Inc Medicare Supplier Location: 3845 Hendersonville Rd, Fletcher, North Carolina 28732 Phone: (828) 684-1644 |
News Archive
Welcome to the world of the law, Supreme Court edition, where after Tuesday's remarkable hearing the five conservative justices appeared eager, or at least willing, to defend an unworkable status quo that rewards people who choose to blow off health insurance coverage knowing that they will be treated anyway if they show up ill at a hospital.
University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi's sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people's skin.
Magnetic Resonance Imaging (MRI) images are usually meant to be static. But now, researchers from Mātai Medical Research Institute (Mātai), Stevens Institute of Technology, Stanford University, the University of Auckland and other institutions, report on an imaging technique that captures the brain in motion in real time, in 3D and in stunning detail, providing a potential diagnostic tool for detecting difficult-to-spot conditions such as obstructive brain disorders and aneurysms - before they become life threatening.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of pancreatic cancer.
› Verified 5 days ago